Nelson: Abnormal Uterine Bleeding: from Terminology to Treatment
Total Page:16
File Type:pdf, Size:1020Kb
Nelson: Abnormal Uterine Bleeding: From Terminology to Treatment Abnormal Uterine Bleeding: Conflict of Interest Disclosure From Terminology to Treatment Anita L. Nelson, MD Grants/ Bayer, Merck, Pfizer, Teva Research Anita L. Nelson, MD Honoraria/ Harbor-UCLA Medical Center Bayer, Merck, Teva Speakers Bureau Consultant/ Agile, Bayer, Advisory Board Merck, Teva, Watson Contraceptive Technology Washington DC – April 17-20, 2013 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 2 Learning Objectives Normal Menstrual Cycle At the end of this presentation, the participants Interval: 24-38 days will be able to Duration: 4.5-8 days State the terminology used to describe abnormal uterine bleeding. Blood loss: 5-80 cc Describe the evaluation needed for women with chronic excessive bleeding. Develop a treatment plan for acute heavy bleeding and for chronic menstrual blood loss which reflects their individual desire for fertility. Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 3 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 4 New Terminology and Menstrual Bleeding Terminology Classification System for Clinical Dimensions Descriptive Normal Limits Abnormal Uterine Bleeding Terms (5th to 95th percentiles) New terms to replace older, imprecise terms Frequency of menses Frequent <24 Bleeding described in 4 dimensions: Normal 24-38 Infrequent >38 Frequency, duration, volume and variability Absent -- English words (heavy, prolonged, infrequent) Regularity of menses, Regular Variation ± 2-20 replace Greek and Latin terms (menorrhagia) cycle-to-cycle days variation over Irregular Variation > 20 Fraser IS, et al. Curr Opin Obstet Gynecol. 2007;19:591-5. 12 months days Woolcock JG, et al. Fertil Steril. 2008;90;2269-80. Fraser IS, et al. Semin Reprod Med. 2011;29:383-90. Fraser IS, et al. Fertil Steril. 2007;87(3):466-76. Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 5 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 6 1 Nelson: Abnormal Uterine Bleeding: From Terminology to Treatment Menstrual Bleeding Terminology PALM-COEIN Classification Clinical Dimensions Descriptive Normal Limits Terms (5th to 95th percentiles) Duration of flow Prolonged >8.0 Normal 4.5-8.0 Shortened <4.5 Volume of monthly Heavy >80 blood loss Normal 5-80 Light <5 Fraser IS, et al. Fertil Steril. 2007;87(3):466-76. Adapted from the Munro. Fertil Steril. 2011;95:2204. Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 7 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 8 PALM-COEIN PALM-COEIN Cases AUB-P Polyps AUB-A Adenomyosis AUB P0 A1 L1→sm M0 C0 O0 E0 I0 N0 AUB-L Leiomyoma SM/O (location) AUB P1 A0 L0 M0 C0 O0 E0 I1 N0 WHO/FIGO subclassification AUB-M Malignancy AUB P0 A0 L1→0 M1 C0 O1 E0 I0 N0 AUB-C Coagulopathy AUB P0 A1 L1→sm M0 C1 O0 E0 I0 N0 AUB-O Ovulatory dysfunction AUB-E Endometrial causes AUB-I Iatrogenic AUB-N Not yet classified Garza-Cavazos A, et al. Female Patient. 2012;37(8):27-36. Garza-Cavazos A, et al. Female Patient. 2012;37(8):27-36. Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 9 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 10 Coding for AUB Coding for AUB 626 Disorders of menstruation and other 626.4 Irregular menstrual cycle, irregular abnormal bleeding from female bleeding, irregular menstruation, genital tract irregular periods 626.0 Amenorrhea (primary)(secondary) 626.5 Ovulation bleeding, regular 626.1 Scanty of infrequent menstruation, intermenstrual bleeding hypomenorrhea, oligomenorrhea 626.6 Metrorrhagia, bleeding unrelated to 626.2 Excessive or frequent menstruation, menstrual cycle, irregular heavy periods, menorrhagia, intermenstrual bleeding menometrorrhagia, polymenorrhea 626.8 Dysfunctional or functional uterine hemorrhage Graza-Cavazos A, et al. Female Patient. 2012;37:27-36. Graza-Cavazos A, et al. Female Patient. 2012;37:27-36. Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 11 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 12 2 Nelson: Abnormal Uterine Bleeding: From Terminology to Treatment Secondary Amenorrhea Secondary Amenorrhea Special Issues Amenorrhea in a reproductive woman Estrogen status determines concerns ≥ 3-6 months in a previously normally Estrogen deficiency osteoporosis, menstruating woman menopausal issues OR Estrogen unopposed endometrial < 9 months or 2 times usual interval carcinoma ASRM. Fertil Steril. 2006;86(5 Suppl):S148-55 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 13 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 14 Common Causes of Chronic Diseases Secondary Amenorrhea Causing Amenorrhea Category Frequency Low or normal FSH: weight loss/anorexia; 66% Uncontrolled Hepatic failure non-specific hypothalamic; chronic anovulation juvenile diabetes Adrenal insufficiency including PCOS; hypothyroidism; Cushing’s syndrome; pituitary tumor, empty sella, End-stage renal Cushing’s syndrome Sheehan syndrome disease Gonadal failure: high FSH 12% Sarcoidosis AIDS 46 XX; abnormal karyotype Acromegaly High prolactin 23% Malabsorption Anatomic: Asherman syndrome 7% Craniopharyngiomas Malignancy Hyperandrogenic states: 2% Thyroid dysfunction ovarian tumor; non-classic CAH; undiagnosed Androgen excess Obesity ASRM. Fertil Steril. 2006;86(5 Suppl):S148-55 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 15 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 16 Medications Causing Amenorrhea Secondary Amenorrhea Differential Diagnosis DMPA, LNG IUS, extended-cycle OCs Pregnancy Chemotherapeutic agents Anesthetics, including cocaine Endocrine disorder Psychoactive drugs: phenothiazines, tricyclic Thyroid dysfunction: TRH increases PRO antidepressants, opiates, chlordiazepoxide, amphetamines, diazepams, haloperidol, fluphenazine, Diabetes mellitus: slowed clearance of chlorpromazine, SSRIs estrogen Antihypertensives: α-methyldopa, reserpine, verapamil Androgen excess: adrenal or ovarian origin Dopamine receptor agonists: metoclopramide Obesity: excess estrogen Antiemetics: sulpiride, promazine, perphenazine Others: cimetidine, cyproheptadine, protease inhibitors Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 17 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 18 3 Nelson: Abnormal Uterine Bleeding: From Terminology to Treatment Menstrual Cycle Workup of Secondary Amenorrhea History: recent surgical procedures, weight changes, medications, other health problems, radiation therapy, chemotherapy Family history: autosomal disorders associated with ovarian failure, endocrinopathy Physical exam: galactorrhea, obstruction, hirsutism, virilization, acromegaly Lab tests: pregnancy test, FSH, TSH, prolactin Other tests if indicated: androgens ASRM. Fertil Steril. 2006;86(5 Suppl):S148-55 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 19 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 20 A Treatment Course of Progestin Progestin Challenge Test Limitations High false positive rate: no withdrawal bleed Up to 20% of women with estrogen have no withdrawal bleeding Androgen excess states common High false negative rate: withdrawal bleeding Up to 40% of women with amenorrhea from Stress, weight loss, exercise or hyperprolactinemia Up to 50% of women with amenorrhea from ovarian failure ASRM. Fertil Steril. 2006;86(5 Suppl):S148-55 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 21 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 22 Ovary Evaluation Work-up of Secondary Amenorrhea Ovary Evaluation High FSH = If FSH and LH elevated and E2 low, consider probable ovarian ovarian failure or (rarely) insensitive ovary failure syndrome Low FSH = pituitary Repeat tests to confirm if early menopause is or hypothalamic suspected etiology Perform karyotype if patient < 30 Rule out autoimmune disease if patient < 35 Common sites affected include thyroid, adrenal, parathyroid, pancreas Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 23 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 24 4 Nelson: Abnormal Uterine Bleeding: From Terminology to Treatment Work-up of Secondary Amenorrhea High Prolactin If gonadotrophins level or low (FSH and LH <5 IU/L) and no response to progestin Persistent hyperprolactinemia without challenge, evaluate pituitary and hypothalamus primary hypothyroidism or medication, evaluate with MRI of pituitary If androgen elevated or high normal If levels in tumor range, order radiographic Pituitary tumor found in 50-60% studies to localize tumor Other CNS lesions High normal testosterone consistent with PCOS or medications Congenital aqueductal stenosis Elevated DHEAS, consider adrenal Adenomas- ACTH, GH hyperfunction Empty sella syndrome Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 25 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 26 CAT Scan or MRI Hypothalamic Amenorrhea Hypothalamic amenorrhea is a diagnosis of Tumor involving exclusion with the pituitary Low-normal gonadotrophins gland Normal PRO Normal imaging of pituitary No withdrawal bleeding Most common cause of amenorrhea, often associated with stress, eating disorders, weight loss?, diabetes?? 72% of women had spontaneous return of menses within 6 years Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 27 Anita L. Nelson, MD HMB 2013- 04-17 CT WDC 28 Secondary Amenorrhea Secondary Amenorrhea Athletic Triad Treatments: Target the Cause Long-Term Consequences Correct thyroid or prolactin dysfunctions Reduced bone mass: particularly harmful in Provide progestin protection for endometrium young adolescents, who should be until normalizes accumulating bone mineralization Estrogen deficient conditions Lipid changes: amenorrheic athletes Provide estrogen and progestin demonstrate increased potential for lipid Unopposed estrogen conditions peroxidation after exercise Provide progestin